Patents Assigned to Kyverna Therapeutics, Inc.
  • METHODS FOR INCREASING T-CELL FUNCTION
    Publication number: 20240158459
    Abstract: Provided herein are methods of increasing T-cell function and T-cells produced by these methods. Also provided herein are methods of treating a subject using T-cells produced by these methods.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 16, 2024
    Applicant: Kyverna Therapeutics, Inc.
    Inventors: John Lee, Erin O’Brien, Jordan Tsai, Lih-Yun Hsu, Faye Wu
  • Methods for increasing T-cell function
    Patent number: 11879003
    Abstract: Provided herein are methods of increasing T-cell function and T-cells produced by these methods. Also provided herein are methods of treating a subject using T-cells produced by these methods.
    Type: Grant
    Filed: October 21, 2022
    Date of Patent: January 23, 2024
    Assignee: Kyverna Therapeutics, Inc.
    Inventors: John Lee, Erin O'Brien, Jordan Tsai, Lih-Yun Hsu, Faye Wu
  • METHODS OF PRODUCING T REGULATORY CELLS, METHODS OF TRANSDUCING T CELLS, AND USES OF THE SAME
    Publication number: 20230330141
    Abstract: This document relates to methods and materials for treating a mammal having an autoimmune disease. For example, materials and methods for producing a T cell comprising a FOXP3 polypeptide. Methods and materials for treating a mammal having an autoimmune disease comprising administering to a mammal having an autoimmune disease an effective amount of a T cell are also provided herein.
    Type: Application
    Filed: November 11, 2022
    Publication date: October 19, 2023
    Applicant: Kyverna Therapeutics, Inc.
    Inventors: Mamle Quarmyne, Faye Wu, Jordan Tsai, John Lee, Jeffrey Greve, Joseph Cheng, Meghana Vijayraghavan
  • METHODS FOR INCREASING T-CELL FUNCTION
    Publication number: 20230174615
    Abstract: Provided herein are methods of increasing T-cell function and T-cells produced by these methods. Also provided herein are methods of treating a subject using T-cells produced by these methods.
    Type: Application
    Filed: October 21, 2022
    Publication date: June 8, 2023
    Applicant: Kyverna Therapeutics, Inc.
    Inventors: John Lee, Erin O'Brien, Jordan Tsai, Lih-Yun Hsu, Faye Wu
  • A METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS
    Publication number: 20230104151
    Abstract: This document relates to methods and materials for treating a mammal having an autoimmune disease. For example, materials and methods for producing a T cell comprising a FOXP3 polypeptide and one or more transcription factors are provided herein. Methods and materials for treating a mammal having an autoimmune disease comprising administering to a mammal having an autoimmune disease an effective amount of a T cell are also provided herein.
    Type: Application
    Filed: November 2, 2022
    Publication date: April 6, 2023
    Applicant: Kyverna Therapeutics, Inc.
    Inventors: Ashley Mahne, John Lee, Lih-Yun Hsu, Jeffrey Greve
  • Method for treating disease using FOXP3+CD4+ T cells
    Patent number: 11446357
    Abstract: This document relates to methods and materials for treating a mammal having an autoimmune disease. For example, materials and methods for producing a T cell comprising a FOXP3 polypeptide and one or more transcription factors are provided herein. Methods and materials for treating a mammal having an autoimmune disease comprising administering to a mammal having an autoimmune disease an effective amount of a T cell are also provided herein.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: September 20, 2022
    Assignee: Kyverna Therapeutics, Inc.
    Inventors: Ashley Mahne, John Lee, Lih-Yun Hsu, Jeffrey Greve